These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19503928)

  • 1. An investigation into the anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U) and 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives.
    Mehellou Y; Balzarini J; McGuigan C
    Org Biomol Chem; 2009 Jun; 7(12):2548-53. PubMed ID: 19503928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives.
    Mehellou Y; McGuigan C; Brancale A; Balzarini J
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3666-9. PubMed ID: 17485204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside mono- and diphosphate prodrugs of 2',3'-dideoxyuridine and 2',3'-dideoxy-2',3'-didehydrouridine.
    Pertenbreiter F; Balzarini J; Meier C
    ChemMedChem; 2015 Jan; 10(1):94-106. PubMed ID: 25209965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoramidate and phosphate prodrugs of (-)-beta-D-(2R,4R)-dioxolane-thymine: synthesis, anti-HIV activity and stability studies.
    Liang Y; Narayanasamy J; Schinazi RF; Chu CK
    Bioorg Med Chem; 2006 Apr; 14(7):2178-89. PubMed ID: 16314108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiviral activity of aryl phosphoramidate derivatives of beta-D- and beta-L-C-5-substituted 2',3'-didehydro-2',3'-dideoxy-uridine bearing linker arms.
    Ladurée D; Fossey C; Delbederi Z; Sugeac E; Schmidt S; Laumond G; Aubertin AM
    J Enzyme Inhib Med Chem; 2005 Dec; 20(6):533-49. PubMed ID: 16408789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro enzymatic and antiviral evaluation of phosphoramidate d4T derivatives as chain terminators.
    Yang S; Pannecouque C; Lescrinier E; Giraut A; Herdewijn P
    Org Biomol Chem; 2012 Jan; 10(1):146-53. PubMed ID: 22069085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells.
    Mehellou Y; Balzarini J; McGuigan C
    ChemMedChem; 2009 Nov; 4(11):1779-91. PubMed ID: 19760699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfoxide-metal exchange for the synthesis of the 2'-tributylstannyl derivative of 2',3'-didehydro-2',3'-dideoxyuridine (d4u): a general entry to 2'-carbon-substituted analogues of d4U.
    Kumamoto H; Onuma S; Tsuchiya K; Egusa Y; Tanaka H; Satoh T
    Nucleosides Nucleotides Nucleic Acids; 2002; 21(4-5):275-86. PubMed ID: 12182344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoramidate protides of carbocyclic 2',3'-dideoxy-2',3'-didehydro-7-deazaadenosine with potent activity against HIV and HBV.
    Gudmundsson KS; Wang Z; Daluge SM; Johnson LC; Hazen R; Condreay LD; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1929-37. PubMed ID: 15628749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl H-phosphonates 17: (N-aryl)phosphoramidates of pyrimidine nucleoside analogues and their synthesis, selected properties, and anti-HIV activity.
    Romanowska J; Sobkowski M; Szymańska-Michalak A; Kołodziej K; Dąbrowska A; Lipniacki A; Piasek A; Pietrusiewicz ZM; Figlerowicz M; Guranowski A; Boryski J; Stawiński J; Kraszewski A
    J Med Chem; 2011 Oct; 54(19):6482-91. PubMed ID: 21834513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency.
    McGuigan C; Harris SA; Daluge SM; Gudmundsson KS; McLean EW; Burnette TC; Marr H; Hazen R; Condreay LD; Johnson L; De Clercq E; Balzarini J
    J Med Chem; 2005 May; 48(10):3504-15. PubMed ID: 15887959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoramidate protides of 2',3'-dideoxy-3'-fluoroadenosine and related nucleosides with potent activity against HIV and HBV.
    Gudmundsson KS; Daluge SM; Johnson LC; Jansen R; Hazen R; Condreay LD; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1953-61. PubMed ID: 14609234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives.
    McGuigan C; Hassan-Abdallah A; Srinivasan S; Wang Y; Siddiqui A; Daluge SM; Gudmundsson KS; Zhou H; McLean EW; Peckham JP; Burnette TC; Marr H; Hazen R; Condreay LD; Johnson L; Balzarini J
    J Med Chem; 2006 Nov; 49(24):7215-26. PubMed ID: 17125274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-beta-D-(arabinofuranosyl)uracil phosphoramidate ProTides.
    Mehellou Y; Balzarini J; McGuigan C
    Antivir Chem Chemother; 2010 Mar; 20(4):153-60. PubMed ID: 20231780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl H-phosphonates. 19. New anti-HIV pronucleotide phosphoramidate diesters containing amino- and hydroxypyridine auxiliaries.
    Romanowska J; Kolodziej K; Sobkowski M; Rachwalak M; Jakubowski T; Golebiewska J; Kraszewski A; Boryski J; Dabrowska A; Stawinski J
    Eur J Med Chem; 2019 Feb; 164():47-58. PubMed ID: 30590257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereospecific chemical and enzymatic stability of phosphoramidate triester prodrugs of d4T in vitro.
    Siccardi D; Gumbleton M; Omidi Y; McGuigan C
    Eur J Pharm Sci; 2004 May; 22(1):25-31. PubMed ID: 15113580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of the phosphoramidate ProTide approach confers micromolar potency against hepatitis C virus on inactive agent 4'-azidoinosine: kinase bypass on a dual base/sugar modified nucleoside.
    McGuigan C; Daverio F; Nájera I; Martin JA; Klumpp K; Smith DB
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3122-4. PubMed ID: 19398331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
    Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
    J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Certain phosphoramidate derivatives of dideoxy uridine (ddU) are active against HIV and successfully by-pass thymidine kinase.
    McGuigan C; Bellevergue P; Sheeka H; Mahmood N; Hay AJ
    FEBS Lett; 1994 Aug; 351(1):11-4. PubMed ID: 8076677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of change in nucleoside structure on the activation and antiviral activity of phosphoramidate derivatives.
    Venkatachalam TK; Samuel P; Qazi S; Uckun FM
    Bioorg Med Chem; 2005 Sep; 13(18):5408-23. PubMed ID: 15994083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.